Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia. [PDF]
Jurczak W +6 more
europepmc +1 more source
Pharmacokinetic/Pharmacodynamic Modelling and Simulation of Lusutrombopag, a Novel Thrombopoietin Receptor Agonist, for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures. [PDF]
Katsube T +4 more
europepmc +1 more source
Avatrombopag, an oral thrombopoietin receptor agonist: results of two double-blind, dose-rising, placebo-controlled Phase 1 studies. [PDF]
Kuter DJ, Allen LF.
europepmc +1 more source
Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study. [PDF]
Neunert C +14 more
europepmc +1 more source
The association of rituximab and a thrombopoietin receptor agonist in high-risk refractory immune thrombocytopenic purpura. [PDF]
Veneri D +3 more
europepmc +1 more source
Real-world use of thrombopoietic agents in treatment-naïve children with severe aplastic anemia: a multicenter retrospective study. [PDF]
Chazli YE +11 more
europepmc +1 more source
Neonatal-Onset Refractory Thrombocytopenia and Anemia Associated With a Homozygous In-Frame NFE2 Duplication. [PDF]
Uddin MS +6 more
europepmc +1 more source
Emerging therapeutic advances for immune thrombocytopenia: highlights from selected early‑phase and pivotal trials at the 2025 ASH annual meeting. [PDF]
Cao L, Wang Z, Xiang Q.
europepmc +1 more source
Case Report: A rare case of primary graft failure after autologous stem cell transplant for mantle cell lymphoma rescued with darbepoetin, eltrombopag, and cyclosporine. [PDF]
Ly SH +6 more
europepmc +1 more source
Coombs-Negative Hemolytic Anemia and Thrombocytopenia Associated With Sarcoidosis Confined to the Spleen and Bone Marrow: A Case Report. [PDF]
Uemura Y, Togitani K, Nakashima J.
europepmc +1 more source

